Translating basic science research to clinical application: Models and strategies for intracerebral hemorrhage

Frontiers in Neurology

Volumn MAY, Issue , 2012, Pages

  Leonardo, Christopher C ^a   Robbins, Sean ^a   Doré, Sylvain ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Behavior; CNS; Inflammation; Ischemia; Preclinical; Rodent; Stroke; Therapy

Indexed keywords

EID: 84865841963     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00085     Document Type: Article

References (114)

1. Adams, H. P. Jr., Del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., Lyden, P. D., Morgenstern, L. B., Qureshi, A. I., Rosenwasser, R. H., Scott, P. A., and Wijdicks, E. F. (2007). Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38,1655-1711.
2. Adeoye, O., Clark, J. F., Kahatri, P., Wagner, K. R., Zuccarello, M., and Pyne-Geithman, G. J. (2011). Do current animal models of intracerebral hemorrhage mirror the human pathology? Transl. Stroke Res. 2, 17-25.
3. Arima, H., Tzourio, C., Anderson, C., Woodward, M., Bousser, M. G., Macmahon, S., Neal, B., and Chalmers, J. (2010). Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 41, 394-396.
4. Aronowski, J.,and Zhao, X. (2011). Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42,1781-1786.
5. Bailey, E. L., Smith, C., Sudlow, C. L., and Wardlaw, J. M. (2011). Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int. J. Stroke 6, 434-444.
6. Beray-Berthat, V., Delifer, C., Besson, V. C., Girgis, H., Coqueran, B., Plotkine, M., Marchand-Leroux, C., and Margaill, I. (2010). Long-term histological and behavioural characterisation of a collagenase-induced model of intracerebral haemorrhage in rats. J. Neurosci. Methods 191, 180-190.
7. Brophy, G. M., Mondello, S., Papa, L., Robicsek, S. A., Gabrielli, A., Tepas, J. III, Buki, A., Robertson, C., Tortella, E C., Hayes, R. L., and Wang, K. K. (2011). Bio-kinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J. Neurotrauma 28, 861-870.
8. Butcher, K., Christensen, S., Parsons, M., De Silva, D. A., Ebinger, M., Levi, C., Jeerakathil, T., Campbell, B. C., Barber, P. A., Bladin, C., Fink, J., Tress, B., Donnan, G. A., and Davis, S. M. (2010). Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke 41, 72-77.
9. Castellanos, M., Leira, R., Serena, J., Blanco, M., Pedraza, S., Castillo, J., and Davalos, A. (2004). Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35, 1671-1676.
10. Chen, J., Cui, X., Zacharek, A., Cui, Y., Roberts, C., and Chopp, M. (2011). White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke 42,445-452.
11. Christie, R., Yamada, M., Moskowitz, M., and Hyman, B. (2001). Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am. J. Pathol. 158, 1065-1071.
12. Cramer, S. C. (2008). Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann. Neurol. 63, 272-287.
13. Cucchiara, B., Messe, S., Sansing, L., Kasner, S., and Lyden, P. (2008). Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 39, 2993-2996.
14. Del Bigio, M. R., Yan, H. J., Buist, R., and Peeling, J. (1996). Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. Stroke 27, 2312-2319; discussion 2319-2320.
15. Dirnagl, U. (2010). Standard operating procedures (SOP) in experimental stroke research: SOP for middle cerebral artery occlusion in the mouse. Nat. Precedings 19, 1-10.
16. Dvorak, F., Haberer, I., Sitzer, M., and Foerch, C. (2009). Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc. Dis. 27, 37-41.
17. Eisenberg, H. M., Gary, H. E. Jr., Aldrich, E. F., Saydjari, C., Turner, B., Foulkes, M. A., Jane, J. A., Marmarou, A., Marshall, L. F., and Young, H. E (1990). Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J. Neurosurg. 73, 688-698.
18. England, T. J., Bath, P. M., Sare, G. M., Geeganage, C., Moulin, T., O'Neill, D., Woimant, F., Christensen, H., De Deyn, P., Leys, D., and Ringelstein, E. B. (2010). Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke 41, 2834-2839.
19. Fan, X., Qiu, J., Yu, Z., Dai, H., Singhal, A. B., Lo, E. H., and Wang, X. (2012). A rat model of studying tissue-type plasminogen activator thromboly-sis in ischemic stroke with diabetes. Stroke 43, 567-570.
20. Farhat, H. I. (2011). Cerebral arteriove-nous malformations. Dis. Mon. 57, 625-637.
21. Fiebach, J. B., Schellinger, P. D., Jansen, O., Meyer, M., Wilde, P., Bender, J., Schramm, P., Juttler, E., Oehler, J., Hartmann, M., Hahnel, S., Knauth, M., Hacke, W., and Sartor, K. (2002). CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower inter-rater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33,2206-2210.
22. Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., and Lo, E. H. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250.
23. Flibotte, J. J., Hagan, N., O'Donnell, J., Greenberg, S. M., and Rosand, J. (2004). Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63, 1059-1064.
24. Foerch, C., Arai, K., Jin, G., Park, K. P., Pallast, S., Van Leyen, K., and Lo, E. H. (2008). Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 39, 3397-3404.
25. Foerch, C., Curdt, I., Yan, B., Dvorak, F., Hermans, M., Berkefeld, J., Raabe, A., Neumann-Haefelin, T., Steinmetz, H., and Sitzer, M. (2006). Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatr. 77, 181-184.
26. Foerch, C., Montaner, J., Furie, K. L., Ning, M. M., and Lo, E. H. (2009). Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology 73, 393-399.
27. Foerch, C., Niessner, M., Back, T., Bauerle, M., De Marchis, G. M., Ferbert, A., Grehl, H., Hamann, G. F., Jacobs, A., Kastrup, A., Klimpe, S., Palm, F., Thomalla, G., Worthmann, H., and Sitzer, M. (2012). Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin. Chem. 58, 237-245.
28. Foerch, C., Wunderlich, M. T., Dvorak, F., Humpich, M., Kahles, T., Goertler, M., Alvarez-Sabin, J., Wallesch, C. W., Molina, C. A., Steinmetz, H., Sitzer, M., and Montaner, J. (2007). Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38, 2491-2495.
29. Fryer, J. D., Taylor, J. W., Demattos, R. B., Bales, K. R., Paul, S. M., Parsadan-ian, M., and Holtzman, D. M. (2003). Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J. Neurosci. 23,7889-7896.
30. Greenberg, S. M., Eng, J. A., Ning, M., Smith, E. E., and Rosand, J. (2004). Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 35,1415-1420.
31. Hartz, A. M., Bauer, B., Soldner, E. L., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klune-mann, H. H., Schuierer, G., and Schlachetzki, F. (2012). Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514-523.
32. Hernandez-Guillamon, M., Delgado, P., Penalba, A., Rodriguez-Luna, D., Molina, C. A., Rovira, A., Alvarez-Sabin, J., Boada, M., and Montaner, J. (2012). Plasma beta-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. Neu-rodegener. Dis. 10, 320-323.
33. Herzig, M. C., Winkler, D. T., Burg-ermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., Danner, S., Abramowski, D., Sturchler-Pierrat, C., Burki, K., Van Duinen, S. G., Maat-Schieman, M. L., Staufenbiel, M., Mathews, P. M., and Jucker, M. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7, 954-960.
34. Hua, Y., Nakamura, T., Keep, R. F., Wu, J., Schallert, T., Hoff, J. T., and Xi, G. (2006). Long-term effects of experimental intracerebral hemorrhage: the role of iron. J. Neurosurg. 104, 305-312.
35. Hua, Y., Schallert, T., Keep, R. F., Wu, J., Hoff, J. T., and Xi, G. (2002). Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33, 2478-2484.
36. Huang, F. P., Xi, G., Keep, R. F., Hua, Y., Nemoianu, A., and Hoff, J. T. (2002). Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96, 287-293.
37. Iida, S., Baumbach, G. L., Lavoie, J. L., Faraci, F. M., Sigmund, C. D., and Heistad, D. D. (2005). Spontaneous stroke in a genetic model of hypertension in mice. Stroke 36, 1253-1258.
38. Kimberly, W. T., Gilson, A., Rost, N. S., Rosand, J., Viswanathan, A., Smith, E. E., and Greenberg, S. M. (2009). Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72,1230-1235.
39. Kimchi, E. Y., Kajdasz, S., Bacskai, B. J., and Hyman, B. T. (2001). Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo mul-tiphoton microscopy. J. Neuropathol. Exp. Neurol. 60, 274-279.
40. Kingwell, K. (2012). Stroke: brain natri-uretic peptide could be a biomarker for outcomes after cardioembolic stroke. Nat. Rev. Neurol. 8, 60.
41. Kirkman, M. A., Allan, S. M., and Parry-Jones, A. R. (2011). Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J. Cereb. Blood Flow Metab. 31, 2135-2151.
42. Kruyt, N. D., Biessels, G. J., Devries, J. H., and Roos, Y B. (2010). Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat. Rev. Neurol. 6, 145-155.
43. Kucukdeveci, A. A., Tennant, A., Grimby, G., and Franchignoni, F. (2011). Strategies for assessment and outcome measurement in physical and rehabilitation medicine: an educational review. J. Rehabil. Med. 43, 661-672.
44. Lee, J. H., Bacskai, B. J., and Ayata, C. (2012). Genetic animal models of cerebral vasculopathies. Prog. Mol. Biol. Transl. Sci. 105,25-55.
45. Lee, J. Y., Sagher, O., Keep, R., Hua, Y., and Xi, G. (2009). Comparison of experimental rat models of early brain injury after subarach-noid hemorrhage. Neurosurgery 65, 331-343; discussion 343.
46. Liew, H. K., Hsu, C. W., Wang, M. J., Kuo, J. S., Li, T. Y., Peng, H. F., Wang, J. Y., and Pang, C. Y (2012). Therapeutic benefit of urocortin in rats with intracerebral hemorrhage. J. Neurosurg. 116, 193-200.
47. Liu, J., Gao, B. B., Clermont, A. C., Blair, P., Chilcote, T. J., Sinha, S., Flaumenhaft, R., and Feener, E. P. (2011). Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat. Med. 17,206-210.
48. Lopez Valdes, E., Hernandez Lain, A., Calandre, L., Grau, M., Cabello, A., and Gomez-Escalonilla, C. (2000). Time window for clinical effectiveness of mass evacuation in a rat balloon model mimicking an intra-parenchymatous hematoma. J. Neurol. Sci. 174,40-46.
49. MacLellan, C. L., Auriat, A. M., Mcgie, S. C., Yan, R. H., Huynh, H. D., De Butte, M. F., and Colbourne, F. (2006). Gauging recovery after hem-orrhagic stroke in rats: implications for cytoprotection studies. J. Cereb. Blood Flow Metab. 26, 1031-1042.
50. MacLellan, C. L., Langdon, K. D., Churchill, K. P., Granter-Button, S., and Corbett, D. (2009). Assessing cognitive function after intrac-erebral hemorrhage in rats. Behav. Brain Res. 198,321-328.
51. MacLellan, C. L., Paquette, R., and Colbourne, F. (2012). A critical appraisal of experimental intracerebral hemorrhage research. J. Cereb. Blood Flow Metab. 32, 612-627.
52. MacLellan, C. L., Silasi, G.,Auriat, A. M., and Colbourne, F. (2010). Rodent models of intracerebral hemorrhage. Stroke 41, S95-S98.
53. MacLellan, C. L., Silasi, G., Poon, C. C., Edmundson, C. L., Buist, R., Peeling, J., and Colbourne, F. (2008). Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion.J. Cereb. Blood Flow Metab. 28,516-525.
54. Matute, M. C., Masjuan, J., Egido, J. A., Fuentes, B., Simal, P., Diaz-Otero, F., Reig, G., Diez-Tejedor, E., Gil-Nunez, A., Vivancos, J., and Alonso De Lecinana, M. (2012). Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants. Cerebrovasc. Dis. 33, 231-239.
55. McCluskey, L., Campbell, S., Anthony, D., and Allan, S. M. (2008). Inflammatory responses in the rat brain in response to different methods of intra-cerebral administration. J. Neuroimmunol. 194,27-33.
56. Milton, I., Ouyang, D., Allen, C. J., Yanasak, N. E., Gossage, J. R., Alleyne, C. H. Jr., and Seki, T. (2012). Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations. Stroke 43, 1432-1435.
57. Mondello, S., Muller, U., Jeromin, A., Streeter, J., Hayes, R. L., and Wang, K. K. (2011a). Blood-based diagnostics of traumatic brain injuries. Expert Rev. Mol. Diagn. 11, 65-78.
58. Mondello, S., Papa, L., Buki, A., Bullock, M. R., Czeiter, E., Tortella, F. C., Wang, K. K., and Hayes, R. L. (2011b). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit. Care 15,R156.
59. Mondello, S., Robicsek, S. A., Gabrielli, A., Brophy, G. M., Papa, L., Tepas, J., Robertson, C., Buki, A., Scharf, D., Jixiang, M., Akinyi, L., Muller, U., Wang, K. K., and Hayes, R. L. (2010). AlphaII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J. Neurotrauma 27, 1203-1213.
60. Montaner, J., Molina, C. A., Monas-terio, J., Abilleira, S., Arenillas, J. E, Ribo, M., Quintana, M., and Alvarez-Sabin, J. (2003). Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107, 598-603.
61. Mouser, P. E., Head, E., Ha, K. H., and Rohn, T. T. (2006). Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am. J. Pathol. 168,936-946.
62. Moussouttas, M. (2012). Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage. Ther. Adv. Neurol. Disord. 5,43-56.
63. Nath, F. P., Jenkins, A., Mendelow, A. D., Graham, D. I., and Teasdale, G. M. (1986). Early hemodynamic changes in experimental intracerebral hemorrhage. J. Neurosurg. 65, 697-703.
64. NINDS. (2005). Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 36, e23-e41.
65. O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., Van Der Worp, B. H., and Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467-477.
66. Papa, L., Lewis, L. M., Falk, J. L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G. M., Demery, J. A., Dixit, N. K., Ferguson, I., Liu, M. C., Mo, J., Akinyi, L., Schmid, K., Mondello, S., Robertson, C. S., Tortella, F. C., Hayes, R. L., and Wang, K. K. (2011). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. doi: 10.1016/j.annemergmed.2011.08.021. [Epub ahead of print].
67. Park, I. S., Meno, J. R., Witt, C. E., Suttle, T. K., Chowdhary, A., Nguyen, T. S., Ngai, A. C., and Britz, G. W (2008). Subarachnoid hemorrhage model in the rat: modification of the endovas-cular filament model. J. Neurosci. Methods 172, 195-200.
68. Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K., Robertson, C. S., and Hayes, R. L. (2007). Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
69. Poppe, A. Y., Majumdar, S. R., Jeer-akathil, T., Ghali, W., Buchan, A. M., and Hill, M. D. (2009). Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 32, 617-622.
70. Power, C., Henry, S., Del Bigio, M. R., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., and Peeling, J. (2003). Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53, 731-742.
71. Quintas, R., Cerniauskaite, M., Ajo-valasit, D., Sattin, D., Boncoraglio, G., Parati, E. A., and Leonardi, M. (2012). Describing functioning, disability, and health with the international classification of functioning, disability, and health brief core set for stroke. Am. J. Phys. Med. Rehabil. 91,S14-S21.
72. Qureshi, A. I., Mendelow, A. D., and Hanley, D. F. (2009). Intracerebral haemorrhage. Lancet 373, 1632-1644.
73. Qureshi, A. I., Suri, M. F., Ling, G. S., Khan, J., Guterman, L. R., and Hopkins, L. N. (2001). Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage. Neurosurgery 49, 416-420; discussion 421.
74. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Bor-den, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Kissela, B. M., Kittner, S. J., Lackland, D. T., Licht-man, J. H., Lisabeth, L. D., Makuc, D. M., Marcus, G. M., Marelli, A., Matchar, D. B., Moy, C. S., Mozaf-farian, D., Mussolino, M. E., Nichol, G., Paynter, N. P., Soliman, E. Z., Sor-lie, P. D., Sotoodehnia, N., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D., and Turner, M. B. (2012). Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125, e2-e220.
75. Rosell, A., Foerch, C., Murata, Y., and Lo, E. H. (2008). Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir. Suppl. 105, 173-178.
76. Rosenberg, G. A., Mun-Bryce, S., Wesley, M., and Kornfeld, M. (1990). Collagenase-induced intracerebral hemorrhage in rats. Stroke 21, 801-807.
77. Rustici, M. C., Chiappini, E., Salvadori, M., Sollai, S., Galli, L., and De Martino, M. (2011). Clinical usefulness of the semiquantitative pro-calcitonin test in the diagnosis of bacterial infections in a third level children's hospital. Clin. Lab. 57, 497-506.
78. Ryu, W. S., Kim, C. K., Kim, B. J., Kim, C., Lee, S. H., and Yoon, B. W. (2012). Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis 220, 581-586.
79. Servadei, F., Murray, G. D., Teasdale, G. M., Dearden, M., Iannotti, F., Lapierre, F., Maas, A. J., Karimi, A., Ohman, J., Persson, L., Stocchetti, N., Trojanowski, T., and Unterberg, A. (2002). Traumatic subarachnoid hemorrhage: demographic and clinical study of 750 patients from the European brain injury consortium survey of head injuries. Neurosurgery 50, 261-267; discussion 267-269.
80. Smith, E. E., and Greenberg, S. M. (2009). Beta-amyloid, blood vessels, and brain function. Stroke 40, 2601-2606.
81. Smith, E. E., Schneider, J. A., Wardlaw, J. M., and Greenberg, S. M. (2012). Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 11, 272-282.
82. STAIR. (1999). Recommendations for standards regarding preclinical neu-roprotective and restorative drug development. Stroke 30,2752-2758.
83. STAIR-II. (2001). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32, 1598-1606.
84. Staykov, D., Wagner, I., Volbers, B., Hauer, E. M., Doerfler, A., Schwab, S., and Bardutzky, J. (2011). Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke 42,2625-2629.
85. Steiner, T., Rosand, J., and Diringer, M. (2006). Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 37, 256-262.
86. Stejskal, D., Sporova, L., Svestak, M., and Karpisek, M. (2011). Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke -a pilot study. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 155,263-268.
87. Su, C. Y., Chen, H. M., Kwan, A. L., Lin, Y. H., and Guo, N. W. (2007). Neuropsychological impairment after hemorrhagic stroke in basal ganglia. Arch. Clin. Neuropsy-chol. 22,465-474.
88. Thai, Q. A., Pradilla, G., Legnani, E G., Kretzer, R. M., Hsu, W., and Tamargo, R. J. (2006). Lysis of intracerebral hematoma with stereo-tactically implanted tissue plas-minogen activator polymers in a rabbit model. J. Neurosurg. 105, 424-429.
89. Van Dorpe, J., Smeijers, L., Dewachter, I., Nuyens, D., Spittaels, K., Van Den Haute, C., Mercken, M., Moechars, D., Laenen, I., Kuiperi, C., Bruynseels, K., Tesseur, I., Loos, R., Vanderstichele, H., Checler, E, Sciot, R., and Van Leuven, E (2000). Prominent cerebral amyloid angiopathy in trans-genic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathol. 157, 1283-1298.
90. Vasilevko, V., Passos, G. F., Quiring, D., Head, E., Kim, R. C., Fisher, M., and Cribbs,D.H. (2010).Agingandcere-brovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunother-apy. Ann. N. Y. Acad. Sci. 1207, 58-70.
91. Vermeer, S. E., Algra, A., Franke, C. L., Koudstaal, P. J., and Rinkel, G. J. (2002). Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 59, 205-209.
92. Vinters, H. V., and Gilbert, J. J. (1983). Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14, 924-928.
93. Viswanathan, A., and Greenberg, S. M. (2011). Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 70, 871-880.
94. Vonsattel, J. P., Myers, R. H., Hedley-Whyte, E. T., Ropper, A. H., Bird, E. D., and Richardson, E. P. Jr. (1991). Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative his-tological study. Ann. Neurol. 30, 637-649.
95. Wagner, K. R., Xi, G., Hua, Y., Klein-holz, M., De Courten-Myers, G. M., Myers, R. E., Broderick, J. P., and Brott, T. G. (1996). Lobar intracerebral hemorrhage model in pigs: rapid edema development in peri-hematomal white matter. Stroke 27, 490-497.
96. Wang, J. (2010). Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog. Neurobiol. 92, 463-477.
97. Wang, J., and Doré, S. (2007). Inflammation after intracerebral hemorrhage.J. Cereb. Blood Flow Metab. 27, 894-908.
98. Wang, J., Fields, J., and Dore, S. (2008). The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood. Brain Res. 1222, 214-221.
99. Wang, J., and Tsirka, S. E. (2005). Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36,613-618.
100. Wasserman, J. K., Yang, H., and Schlichter, L. C. (2008). Glial responses, neuron death and lesion resolution after intracerebral hemorrhage in young vs. aged rats. Eur. J. Neurosci. 28, 1316-1328.
101. Whiteley, W., Tseng, M. C., and Sander-cock, P. (2008). Blood biomark-ers in the diagnosis of ischemic stroke: a systematic review. Stroke 39, 2902-2909.
102. Winkler, D. T., Bondolfi, L., Herzig, M. C., Jann, L., Calhoun, M. E., Wiederhold, K. H., Tolnay, M., Staufenbiel, M., and Jucker, M. (2001). Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J. Neurosci. 21, 1619-1627.
103. Won, S. J., Tang, X. N., Suh, S. W., Yenari, M. A., and Swanson, R. A. (2011). Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production. Ann. Neurol. 70, 583-590.
104. Wu, G., Bao, X., Xi, G., Keep, R. E, Thompson, B. G., and Hua, Y. (2011). Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. J. Neurosurg. 114, 1805-1811.
105. Xi, G., Keep, R. F., and Hoff, J. T. (1998). Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 89, 991-996.
106. Xi, G., Keep, R. F., and Hoff, J. T. (2006). Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 5, 53-63.
107. Xue, M., and Del Bigio, M. R. (2000a). Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 283, 230-232.
108. Xue, M., and Del Bigio, M. R. (2000b). Intracortical hemorrhage injury in rats: relationship between blood fractions and brain cell death. Stroke 31, 1721-1727.
109. Xue, M., and Del Bigio, M. R. (2003). Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats. J. Stroke Cerebrovasc. Dis. 12,152-159.
110. Yang, G. Y., Betz, A. L., Chenevert, T. L., Brunberg, J. A., and Hoff, J. T. (1994). Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J. Neurosurg. 81,93-102.
111. Yang, J., Ji, Y., Mehta, P., Bates, K. A., Sun, Y., and Wisniewski, T. (2011). Blocking the apolipoprotein E/amyloid-beta interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. J. Alzheimers Dis. 24, 269-285.
112. Zekry, D., Duyckaerts, C., Belmin, J., Geoffre, C., Moulias, R., and Hauw, J. J. (2003). Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia. Acta Neuropathol. 106, 367-373.
113. Zhao, X., Song, S., Sun, G., Strong, R., Zhang, J., Grotta, J. C., and Aronowski, J. (2009). Neuroprotec-tive role of haptoglobin after intracerebral hemorrhage. J. Neurosci. 29, 15819-15827.
114. Zhen, G., Kim, Y T., Li, R. C., Yocum, J., Kapoor, N., Langer, J., Dobrowol-ski, P., Maruyama, T., Narumiya, S., and Dore, S. (2011). PGE(2) EP1 receptor exacerbated neu-rotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease. Neurobiol. Aging. doi: 10.1016/j.neurobiolaging.2011.09.017. [Epub ahead of print].